.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Baxter
Colorcon
Cantor Fitzgerald
Johnson and Johnson
Merck
US Army
Fuji
Daiichi Sankyo
Medtronic

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 6,458,836 protect, and when does it expire?


Patent ► Subscribe protects RESCULA and is included in one NDA. There has been one Paragraph IV challenge on Rescula.

This patent has twenty-one patent family members in eighteen countries.

Summary for Patent: ► Subscribe

Title: Treatment of ocular hypertension and glaucoma
Abstract:Disclosed is treatment of ocular hypertension and glaucoma by long-term therapy with a prostaglandin related compound for eliminating or reducing potential iridic pigmentation. Composition useful for the treatment, and use of the prostaglandin related compound for producing the composition are also disclosed.
Inventor(s): Ueno; Ryuji (Potomac, MD)
Assignee: Sucampo, A.G. (Zug, CH)
Application Number:09/900,021
Patent Claim Types:
see list of patent claims
Use; Compound; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sucampo Pharma Llc
RESCULA
unoprostone isopropyl
SOLUTION/DROPS;OPHTHALMIC021214-001Aug 3, 2000DISCNYesNo► Subscribe► Subscribe METHOD OF TREATING OCULAR HYPERTENSION
Sucampo Pharma Llc
RESCULA
unoprostone isopropyl
SOLUTION/DROPS;OPHTHALMIC021214-001Aug 3, 2000DISCNYesNo► Subscribe► Subscribe THE LONG TERM TREATMENT OF PROPHYLACTIC MANAGEMENT OF OCULAR HYPERTENSION AND GLAUCOMA
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Norway20024381► Subscribe
South Korea20080012407► Subscribe
MexicoPA02008967► Subscribe
South Korea20020081438► Subscribe
Japan2003526660► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Cerilliant
McKinsey
Julphar
Federal Trade Commission
US Department of Justice
Chinese Patent Office
Citi
Teva
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot